Publications

The publication of research results is a fundamental requirement for improving treatment concepts across the board. iOMEDICO supports the international guidelines on transparency and publication of medical research results.

We regularly present our data at national and international conferences. Our publications appear in scientifically renowned, international journals. Authors are principal investigators, investigators with a high number of participating patients, and iOMEDICO scientists.

TITEL
STUDIE
JAHR
Histology, metastases and palliative surgery in mRCC patients. Data from a clinical registry – RCC Registry.

Müller, L., Münch, A., Goebell, P., Hübner, A., Koska, M., Marschner, N., 2011.

Onkologie 34 (suppl 6)(P616), 182.

Abstract

Download

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: DGHO / Journal: Onkologie
TNK
2011
Real-life treatment of patients with advanced or metastatic renal cell carcinoma in German oncology and urology outpatient centers (RCC-Registry).

Müller, L., Goebell, P.J., Blumenstengel, K., Lueck, A., Koska, M., Marschner, N., 2011.

J Clin Oncol 29 (suppl 7)(Abstract 367). doi:10.1200/jco.2011.29.7_suppl.367

Abstract

Download

Indikation: Urogenital Tumors, Urogenitale Tumore / Veranstaltung: GCS (ASCO) / Journal: Journal of Clinical Oncology
TNK
2011
A preliminary report of a Phase II study of folinic acid, 5-fluorouracil, irinotecan (FOLFIRI) plus sunitinib with toxicity, efficacy, pharmacokinetics, biomarker, imaging data in patients with colorectal cancer with liver metastases as 1st line treatment.

Mross, K., Büchert, M., Fasol, U., Jaehde, U., Kanefendt, F., Strumberg, D., Arends, J., Hense, J., Moritz, B., Fischer, R., Scheulen, M.E., 2011.

Int J Clin Pharmacol Ther 49, 96–98.

Abstract

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: - / Journal: International Journal of Clinical Pharmacology and Therapeutics
CESAR-C-II-005
2011
Networking Against Cancer.

Marschner, N., Jänicke, M., 2011.

Breast Care 6, 245–247. doi:10.1159/000329716

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: - / Journal: Breast Care
Registerübergreifend
2011
Tumorregister Lymphatische Neoplasien – Klinisches Register zur Darstellung der Behandlungsrealität und der Therapiemodalitäten bei behandlungsbedürftigen malignen lymphatischen Systemerkrankungen der Tumorentitäten Non-Hodgkin-Lymphome, Chronische Lymphatische Leukämie und Multiples Myelom.

Knauf, W., Abenhardt, W., 2011.

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: CLL-Studientreffen / Journal: -
TLN
2011
Epidemiologisches Register zur Darstellung der Behandlungsrealität und der Therapiemodalitäten bei behandlungsbedürftigen malignen lymphatischen Systemerkrankungen der Tumorentitäten Non-Hodgkin-Lymphome, Chronische Lymphatische Leukämie und Multiples Myelom.

Knauf, W., Abenhardt, W., 2011.

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: Myelom Kongress / Journal: -
TLN
2011
How to Treat Chronic Lymphocytic Leukemia? Data From a Clinical Registry by Office-Based Hematologists in Germany (TLN Registry).

Knauf, W., Abenhardt, W., Aldaoud, A., Lerchenmuller, C., Koska, M., Marschner, N., 2011.

Blood 118(21), 4606.

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: ASH / Journal: Blood
TLN
2011
Age-dependent differences in treatment of patients with Multiple Myeloma and Chronic Lymphocytic Leukaemia in outpatient cancer centres in Germany. Data from a clinical registry – TLN Registry.

Knauf, W., Abenhardt, W., Aldaoud, A., Lerchenmüller, C., Koska, M., Marschner, N., 2011.

Onkologie 34 (suppl 6)(V118), 21. doi:10.1159/000333299

Abstract

Indikation: Haemoblastoma, Hämoblastosen / Veranstaltung: DGHO / Journal: Onkologie
TLN
2011
Biomarker response on exposure to sunitinib and its primary metabolite (SU12662) in metastatic colorectal cancer patients.

Kanefendt, F., Lindauer, A., Kinzig, M., Strumberg, D., Scheulen, M.E., Mross, K., Fischer, R., Moritz, B., Sörgel, F., Jaehde, U., 2011.

Int J Clin Pharmacol Ther 49, 88–90.

Abstract

Indikation: Colorectal Cancer, Kolorektalkarzinom / Veranstaltung: - / Journal: International Journal of Clinical Pharmacology and Therapeutics
CESAR-C-II-005
2011
Capecitabine (Cap) combined with bevacizumab (Bev) with or without vinorelbine (Vin) in first-line metastatic breast cancer (MBC): First safety results from the randomized CARIN trial.

Hegewisch-Becker, S., Lerchenmüller, C.A., Welt, A., Decker, T., Just, M., Steffens, C., Hipper, A., Marschner, N., 2011.

J Clin Oncol (Meeting Abstracts). 2011;29(suppl; abstract 1044). doi: 10.1200/jco.2011.29.15_suppl.1044

Abstract

Indikation: Breast Cancer, Mammakarzinom / Veranstaltung: ASCO / Journal: Journal of Clinical Oncology
CARIN
2011